Dec 03, 2025
773:584
For every 584 shares held, investors received 773. The price per share adjusted from $4.17 to $3.15.
The split itself did not change the total investment value.
Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda (EGX:RMDA) operates in the Pharmaceuticals: major industry.
Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda company overviewTenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda's most recent stock split was on December 3, 2025. It was a 773-for-584 forward split, so shareholders received 773 shares for every 584 they held.
Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda (EGX:RMDA) has split its stock 3 times: a 121-for-93 split on September 23, 2021, a 1419-for-932 split on September 21, 2023, and a 773-for-584 split on December 3, 2025.
Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda has split its stock 3 times. This history records 3 forward splits between September 23, 2021 and December 3, 2025.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda's 773-for-584 split on December 3, 2025, every 584 shares became 773 shares.
Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda has not announced a new split in our records. Its most recent split was on December 3, 2025, less than a year ago. Companies announce splits in advance, and any new EGX:RMDA split will appear on this page.
Already premium?